rpthjournal.org
Cautious use of activated prothrombin complex concentrate in patients receiving emicizumab: new evidence and clinical considerations
Emicizumab (EMI), a bispecific monoclonal antibody that mimics the function of activated factor (F)VIII and is not recognized by anti-FVIII antibodies, has established itself as the prophylactic…